GEN - Genetic Engineering and Biotechnology News41m
Inhibiting FGFR2 Supports Prevention and Delay of Common Pancreatic Cancer
Results showed that FGFR2 gene deletion led to significantly fewer precancerous lesions and delayed PDAC tumor formation compared with mice with an intact FGFR2 gene. In addition, the combined ...
News-Medical.Net7h
FGFR2 identified as key driver in KRAS-mutated pancreatic cancer progression
Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...
Science Daily8h
In pancreatic cancer, a race against time
Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...
Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers
In a recent study, precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS ...
This Pharma Stock Is Gaining Major Steam Ahead Of Opening Bell
Real-time index price for TSX Materials Capped Index (TTMT), along with buy or sell indicators, analysis, charts, historical ...